To access this material please log in or register

Register Authorize

Non-cardiac surgery after coronary stenting: Current view of the issue

Sumin A. N.

Keywords: non-cardiac surgery, stenting, surgical therapy

DOI: 10.18087/rhj.2014.4.1908

Cardiac complications are the major cause of perioperative mortality in non-cardiac interventions. As invasive cardiology progressively develops, more patients undergo non-cardiac operations after transcatheter coronary interventions. After coronary stenting, double antiplatelet therapy (DAT) is required on a long-term basis. If during this therapy non-cardiac surgery is needed a difficult clinical dilemma emerges: DAT continuation would increase the risk of perioperative bleeding whereas DAT discontinuation would increase the risk of stent thrombosis. This review is focused on recent literature on this issue with a critical analysis and comparison to current recommendations of experts.
  1. Dehmer GJ,Weaver D, Roe MT et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J AmColl Cardiol. 2012;60 (20):2017–31.
  2. Berger PB, Kleiman NS, Pencina MJ et al; EVENT Investigators. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv. 2010;3 (9):920–7.
  3. Gandhi NK, Abdel-Karim AR, Banerjee S, Brilakis ES. Frequency and risk of noncardiac surgery after drug-eluting stent implantation. Catheter Cardiovasc Interv. 2011;77 (7):972–6.
  4. Wijeysundera DN, Wijeysundera HC, Yun L et al. Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study. Circulation. 2012;126 (11):1355–62.
  5. Hawn MT, Graham LA, Richman JS et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA. 2013;310 (14):1462–72.
  6. Alshawabkeh LI, Banerjee S, Brilakis ES. Systematic review of the frequency and outcomes of non-cardiac surgery after drug-eluting stent implantation. Hellenic J Cardiol. 2011;52 (2):141–48.
  7. To AC, Armstrong G, Zeng I, Webster MW. Noncardiac surgery and bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv. 2009;2 (3):213–21.
  8. Kaluza GL, Joseph J, Lee JR et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000;35 (5):1288–94.
  9. Poldermans D, Schouten O, Vidakovic R et al. DECREASE Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol. 2007;49 (17):1763–69.
  10. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol. 2007;49 (22):2145–50.
  11. Poldermans D, Bax JJ, Boersma E et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and European Society of Anaesthesiology (ESA). Eur Heart J. 2009;30 (22):2769–2812.
  12. Fleisher LA, Beckman JA, Brown KA et al. American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society ‑for Vascular Medicine; Society for Vascular Surgery. 2009 ACCF / AHA focused update on perioperative beta blockade incorporated into the ACC / AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol. 2009;54 (22):e13‑e118.
  13. Прогнозирование и профилактика кардиальных осложнений внесердечных хирургических вмешательств. Национальные рекомендации. Приложение 3 к журналу Кардиоваскулярная терапия и профилактика 2011;10 (6):3–28.
  14. Rabbitts JA1, Nuttall GA, Brown MJ et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology. 2008 Oct;109 (4):596–604.
  15. Douketis JD, Berger PB, Dunn AS et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133 (6 Suppl): 299S-339S.
  16. Brilakis ES, Banerjee S. Patient with coronary stents needs surgery: what to do? JAMA. 2013 Oct 9;310 (14):1451–2.
  17. Brilakis ES, Patel VG, Banerjee S. Medical management after coronary stent implantation: a review. JAMA. 2013;310 (2):189–98.
  18. Illuminati G, Ricco JB, Greco C et al. Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial. Eur J Vasc Endovasc Surg. 2010;39 (2):139–45.
  19. Alshawabkeh L, Prasad A, Lenkovsky F. Outcomes of a preoperative «bridging» strategy with glycoprotein IIb / IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration. EuroIntervention. 2013;9 (2):204–11.
  20. Rassi AN, Blackstone E, Militello MA et al. Safety of «bridging» with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery. Am J Cardiol. 2012;110 (4):485–90.
  21. Savonitto S, D’Urbano M, Caracciolo M et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of ‘bridging’ antiplatelet therapy with tirofiban du­ring temporary withdrawal of clopidogrel. Br J Anaesth. 2010;104 (3):285–91.
  22. Барбараш Л. С., Сумин А. Н., Барбараш О. Л., Иванов С. В. Оценка и коррекция периоперационного риска сердечно-сосу­дистых осложнений при некардиальных операциях. Кардиология. 2012;52 (5):77–87.
  23. Фроловичева И. С., Мозжухина Н. В., Чомахидзе П. Ш. и др. Оценка риска развития сердечно-сосудистых осложнений при некардиологических вмешательствах: основные рекомендации и клинические наблюдения. Кардиология и сердечно-сосудистая хирургия. 2013;3:94–100.
  24. McFalls EO, Ward HB, Moritz TE et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351 (27):2795–804.
  25. Landesberg G, Mosseri M. PRO: Preoperative coronary revascularization in high-risk patients undergoing vascular surgery. Anesth Analg. 2008;106 (3):759–63.
  26. Чернявский А. М., Карпенко А. А., Рахметов Н. Р. и др. Выбор и этапность хирургического вмешательства у больных с инфраренальной аневризмой брюшной аорты при сочетанном поражении коронарного русла и брахиоцефальных артерий. Ангиология и сосудистая хирургия. 2011;17 (3):111–9.
  27. Сумин А. Н., Корок Е. В., Панфилов С. Д. и др. Реваскуляризация миокарда у больных ишемической болезнью сердца перед операциями на брюшной аорте. Кардиология. 2013;53 (4):62–7.
  28. Monaco M, Stassano P, Di Tommaso L et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients. A prospective, randomized study. J Am Coll Cardiol. 2009;54 (11):989–96.
  29. Erasmus Medical Centre. Report on the 2012 follow-up investigation of possible breaches of academic integrity. 2012. Available at: http://cardiobrief.files.wordpress.com / 2012 / 10 / integrityreport-2012–10‑english-translation.pdf (accessed 10 Jul 2013).
  30. Kiemeneij F1, Serruys PW, Macaya C et al. Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol. 2001 May;37 (6):1598–603.
  31. Beijk MA, Klomp M, Verouden NJ et al. Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eur Heart J. 2010;31 (9):1055–64.
  32. Ганюков В. И., Бохан Н. С., Тарасов Р. С. и др. Сокращенная терапия клопидогрелем при использовании стентов с биоинженерным покрытием, как компонент этапного лечения больных мультифокальным атеросклерозом. Медицина в Кузбассе. 2012;11 (4):4–9.
  33. Попов В. А., Ганюков В. И., Козырин К. А. и др. Шунтирование передней межжелудочковой артерии из переднебоковой миниторакотомии. Ангиология и сосудистая хирургия. 2012;2:117–22.
Sumin A. N. Non-cardiac surgery after coronary stenting: Current view of the issue. Russian Heart Journal. 2014;78 (4):216–223

To access this material please log in or register

Register Authorize
Ru En